Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study

L Kumar, S Melinkeri, P Ganesan, J Kumar… - Future …, 2024 - Taylor & Francis
Aim: To assess the safety and effectiveness of daratumumab monotherapy in Indian patients
with relapsed/refractory multiple myeloma. Methods: In this prospective, multicenter, phase …
被引用次数：1 相关文章

Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study.

L Kumar, S Melinkeri, P Ganesan, J Kumar… - Future Oncology …, 2023 - europepmc.org
Aim: To assess the safety and effectiveness of daratumumab monotherapy in Indian patients
with relapsed/refractory multiple myeloma. Methods: In this prospective, multicenter, phase …

Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study

L Kumar, S Melinkeri, P Ganesan… - Future oncology …, 2024 - pubmed.ncbi.nlm.nih.gov
Aim: To assess the safety and effectiveness of daratumumab monotherapy in Indian patients
with relapsed/refractory multiple myeloma. Methods: In this prospective, multicenter, phase …